NBIX vs XOSWW · P/E 45, rev $1.77B vs rev $56.0M
Neurocrine Biosciences Inc (NBIX) versus Xos Equity Warrants (XOSWW) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Xos Equity Warrants (XOSWW) is a automobiles & auto parts company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported XOSWW revenue for 2024-12-31 was $56.0M. Net income was -$50.2M. Revenue was up 25.7% from 2023-12-31 to 2024-12-31. XOSWW currently screens at market cap $0.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. XOSWW currently screens at market cap $0.
Not investment advice. Open the NBIX and XOSWW stock pages for the full models.
Not investment advice.